Home Newsfeeds SEC Considers Easing Climate-Disclosure Rules as It Completes Proposal

SEC Considers Easing Climate-Disclosure Rules as It Completes Proposal

-Wall Street Journla

byCharles Gross

February 3, 2023

1 minute read

-Wall Street Journla

Legal
News

10x Genomics Comments On Second UPC Preliminary Injunction Decision After UPC Denies Second Preliminary Injunction Request; Prior Injunctions Against NanoString’s CosMx Products In Europe Remain In Full Effect

By Benzinga Newsdesk

October 10, 12:08 PM

10x Genomics, Inc. (NASDAQ:TXG), a leader in single cell and spatial biology, announced today that the European Unified Patent Court ("UPC") has declined to issue a second preliminary injunction against NanoString

NSTG

News

Reported Sunday, Regeneron Pharmaceuticals Presented Pivotal Data On Linvoseltamab At AACR 2024, Reinforcing A High Response Rate That Deepens Over Time In Patients With Heavily Pre-Treated Multiple Myeloma

By Benzinga Newsdesk

April 8, 2:37 AM

With an 11-month median duration of follow up, the linvoseltamab data among 117 patients presented at AACR reinforce the strength of previously shared findings and included a: 71% objective response rate (ORR),

REGN

News
Rumors

“AMD Zen 5 Threadripper 8000 ‘Shimada Peak’ CPUs Rumored For 2025” – Tom’s Hardware

By Benzinga Newsdesk

April 28, 2:27 PM

https://www.tomshardware.com/news/amd-roadmap-2026-shimada-peakAMD is keeping the pedal to the metal, as evidenced by a host of new processors name-checked in a DigiTimes report today. Probably of greatest interest to PC

AMD

News

Verint Financial Compliance Achieves Microsoft Co-Sell Ready Status And Inclusion In The Microsoft AppSource Marketplace

By Benzinga Newsdesk

November 14, 9:50 AM

Verint® (NASDAQ:VRNT), The Customer Engagement Company®, today announced that Verint Financial Compliance™ has earned co-sell ready status with Microsoft and is now available in the Microsoft AppSource

MSFT

SEC Considers Easing Climate-Disclosure Rules as It Completes Proposal

Related Posts

10x Genomics Comments On Second UPC Preliminary Injunction Decision After UPC Denies Second Preliminary Injunction Request; Prior Injunctions Against NanoString’s CosMx Products In Europe Remain In Full Effect

Reported Sunday, Regeneron Pharmaceuticals Presented Pivotal Data On Linvoseltamab At AACR 2024, Reinforcing A High Response Rate That Deepens Over Time In Patients With Heavily Pre-Treated Multiple Myeloma

“AMD Zen 5 Threadripper 8000 ‘Shimada Peak’ CPUs Rumored For 2025” – Tom’s Hardware

Verint Financial Compliance Achieves Microsoft Co-Sell Ready Status And Inclusion In The Microsoft AppSource Marketplace